Synthesis of carbocyclic 1-14-(hydroxymethyl)cyclopent-2-enyl]-1,2,4-triazole-3-carboxamide and its derivatives

Nucleosides, Nucleotides and Nucleic Acids

Volumn 22, Issue 4, 2003, Pages 437-451

  An, Gwang il ^a   Rhee, Hakjune ^a  

^a Hanyang University   (South Korea)

Author keywords

Carbocyclic nucleoside; Carbocyclic ribavirin analogues; Coupling reaction; Pd(0) catalyzed

Indexed keywords

1,2,4 TRIAZOLE 3 CARBOXAMIDE; 1,2,4 TRIAZOLE DERIVATIVE; 1,2,4-TRIAZOLE-3-CARBOXAMIDE; ANTIVIRUS AGENT; CARBOCYCLIC 1 (4 (HYDROXYMETHYL)CYCLOPENT 2 ENYL) 1,2,4 TRIAZOLE 3 CARBOXAMIDE; CARBOCYCLIC 1 [4 (HYDROXYMETHYL)CYCLOPENT 2 ENYL] 1,2,4 TRIAZOLE 3 CARBOXAMIDE DERIVATIVE; CARBOCYCLIC 1-(4-(HYDROXYMETHYL)CYCLOPENT-2-ENYL)-1,2,4-TRIAZOLE-3-CARBOXAMIDE; CARBOXYLIC ACID; CYCLOPENTANE DERIVATIVE; CYCLOPENTENE DERIVATIVE; NUCLEOSIDE; PALLADIUM; RIBAVIRIN; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CATALYST; CHEMICAL ANALYSIS; CHEMICAL REACTION; CHEMICAL STRUCTURE; CHEMISTRY; DERIVATIZATION; SYNTHESIS;

ACIDS, CARBOCYCLIC; ANTIVIRAL AGENTS; CYCLOPENTANES; NUCLEOSIDES; PALLADIUM; RIBAVIRIN; TRIAZOLES;

EID: 0037773495     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-120022033     Document Type: Article

References (49)

1. (a) Agrofoglio, L.; Suhas, E.; Farese, A.; Condom, R.; Challand, S.R.; Earl, R.A.; Guedj, R. Tetrahedron 1994, 50, 10,611-10,670;
2. (b) Borthwick, A.D.; Biggadike, K. Tetrahedron 1992, 48, 571-623;
3. (c) Huryn, D.M.; Okabe, M. Chem. Rev. 1992, 92, 1745-1768;
4. (d) Marquez, V.E.; Lim, M.I. Med. Res. Rev. 1986, 6, 1-40;
5. (e) Hobbs, J.B. In Comprehensive Medicinal Chemistry; Hansch, C., Sammers, P.G., Taylor, J.B., Eds.; Pergamon: Oxford, 1990; Vol. 2, 306-322.
6. (f) Hovi, T. In Antiviral Agents: The Development and Assessment of Antiviral Chemotherapy; Field, H.J., Ed.; CRC Press: 1988; Chapter 1, 1-12.
7. (a) Katagiri, N.; Takebayashi, M.; Kokufuda, H.; Kaneko, C.; Kanehira, K.; Torihara, M. J. Org. Chem. 1997, 62, 1580-1581;
8. (b) Berranger, T.; Langlois, Y. Tetrahedron Lett. 1995, 36, 5523-5526;
9. (c) Hildebrand, S.; Troxler, T.; Scheffold, R. Helv. Chim. Acta 1994, 77, 1236-1240;
10. (d) Legraverend, M.; Aubertin, A.M.; Obert, G.; Huel, C.; Bisagni, E. Nucleosides Nucleotides 1994, 13, 915-923;
11. (e) Diaz, M.; Ibarzo, J.; Jimenez, J.M.; Ortuno, R.M. Tetrahedron: Asymmetry 1994, 5, 129-140;
12. (f) Jung, M.E.; Rhee, H. J. Org. Chem. 1994, 59, 4719-4720;
13. (g) Nokami, J.; Matsuura, H.; Nakasima, K.; Shibata, S. Chem. Lett. 1994, 1071-1074;
14. (h) Asami, M.; Takahashi, J.; Inoue, S. Tetrahedron: Asymmetry 1994, 5, 1649-1652;
15. (i) Hodgson, D.M.; Witherington, J.; Moloney, B.A. J. Chem. Soc., Perkin Trans. 1 1994, 3373-3378;
16. (j) MacKeith, R.A.; McCague, R.; Olivo, H.F.; Palmer, C.F.; Roberts, S.M. J. Chem. Soc., Perkin Trans. 1 1993, 313-314;
17. (k) Jung, M.E.; Rhee, H. Tetrahedron Lett. 1993, 34, 4449-4452;
18. (l) Evans, C.T.; Roberts, S.M.; Shoberu, K.A.; Sutherland, A.G. J. Chem. Soc., Perkin Trans. 1 1992, 589-592;
19. (m) Trost, B.M.; Li, L.; Guile, S.D. J. Am. Chem. Soc. 1992, 114, 8745-8747;
20. (n) Peel, M.R.; Sternbach, D.D.; Johnson, M.R. J. Org. Chem. 1991, 56, 4990-4993.
21. (a) Daluge, S.M.; Martin, M.T.; Sickles, B.R.; Livingston, D.A. Nucleosides Nucleotides Nucleic Acids 2000, 19, 297-327;
22. (b) Olivo, H.F.; Yu, J. J. Chem. Soc., Perkin Trans. 1 1998, 391-392;
23. (c) Daluge, S.M.; Good, S.S.; Faletto, M.B.; Miller, W.H.; Clair, M.H.S.; Boone, L.R.; Tisdale, M.; Parry, N.R.; Reardon, J.E.; Dornsife, R.E.; Averett, D.R.; Krenitsky, T.A. Antimicrob. Agents Chemother. 1997, 41, 1082-1093;
24. (d) Faletto, M.B.; Miller, W.H.; Garvey, E.P.; Clair, M.H.S.; Daluge, S.M.; Good, S.S. Antimicrob. Agents Chemother. 1997, 41, 1099-1107;
25. (e) Crimmins, M.T.; King, B.W. J. Org. Chem. 1996, 61, 4192-4193;
26. (f) Kimberlin, D.W.; Coen, D.M.; Biron, K.K.; Cohen, J.I.; Lamb, R.A.; McKlinlay, M.; Emini, E.A.; Whitley, R.J. Antiviral Res. 1995, 26, 369-401;
27. (g) Daluge, S.M. U.S. Patent 5,034,394, Therapeutic nucleosides, 1991.
28. (a) An, G.; Rhee, H. Nucleosides Nucleotides Nucleic Acids 2000, 19, 1111-1122;
29. (b) Kim, W.; Kim, H.; Rhee, H. Heterocycles 2000, 53, 219-224;
30. (c) Rhee, H.; Yoon, D.; Jung, M.E. Nucleosides Nucleotides 2000, 3, 619-628;
31. (d) Crimmins, M.T.; Zuercher, W.J. Org. Lett. 2000, 2, 1065-1067;
32. (e) Crimmins, M.T.; King, B.W.; Zuercher, W.J.; Choy, A.L. J. Org. Chem. 2000, 65, 8499-8509;
33. (f) Crimmins, M.T. Tetrahedron 1998, 54, 9229-9272;
34. (g) Olivo, H.F.; Yu, J. Tetrahedron: Asymmetry 1997, 8, 3785-3788;
35. (h) Akella, L.B.; Vince, R. Tetrahedron 1996, 52, 2789-2794;
36. th Annual Meeting of the Korean Chemical Society, Poster Session, oct. 18-19, 1996;
37. (j) Konkel, M.J.; Vince, R. Tetrahedron 1996, 52, 799-808;
38. (k) Konkel, M.J.; Vince, R. Nucleosides Nucleotides 1995, 14, 2061-2077.
39. (a) Kuang, R.; Ganguly, A.K.; Chan, T.M.; Pramanik, B.N.; Blythin, D.J.; McPhail, A.T.; Saksena, A.K. Tetrahedron Lett. 2000, 41, 9575-9579;
40. (b) Kapeller, H.; Marschner, C.; Weißenbacher, M.; Griengl, H. Tetrahedron 1998, 54, 1439-1456.
41. (c) Noble, S.A.; Beddall, N.E.; Beveridge, A.J.; Marr, C.L.P.; Mo, C.L.; Myers, P.L.; Penn, C.R.; Storer, R.; Woods, J.M. Nucleosides Nucleotides 1991, 10, 487-490.
42. (a) An, G.; Rhee, H. Nucleosides Nucleotides Nucleic Acids 2002, 21, 65-72;
43. (b) MacKeith, R.A.; McCague, R.; Olivo, H.F.; Roberts, S.M.; Taylor, S.J.C.; Xiong, H. Bioorg. Med. Chem. 1994, 2, 387-394;
44. (c) Lubineau, A.; Auge, J.; Lubin, N. Tetrahedron Lett. 1991, 32, 7529-7530.
45. (a) Benson, S.C.; Gross, J.L.; Snyder, J.K. J. Org. Chem. 1990, 55, 3257-3269;
46. (b) Boger, D.L.; Panek, J.S.; Yasuda, M. Org. Synth. 1987, 66, 142-150;
47. (c) Scheibye, S.; El-Barbary, A.A.; Lawesson, S.-O.; Fritz, H.; Rihs, G. Tetrahedron 1982, 38, 3753-3760.
48. Still, W.C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923-2925.
49. Armarego, W.L.F.; Perin, D.D. Purification of Laboratory Chemicals, 4th Ed.; Butterworth-Heinemann, 1996.